Neurodegeneration, an continuous decline in the functionality of neurons, presents a significant challenge to modern medicine. While there is currently no cure for neurodegenerative diseases, researchers are vigorously exploring novel therapeutic approaches. One such direction of research involves deschloroketamine, a modified form of the anestheti